Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-18Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-18An Open-label, Multicenter Extension Study Evaluating the Patient Perspective of the Physical Impact of Multiple Sclerosis and Providing Continued Access to Ocrelizumab in Patients With Multiple Sclerosis Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Study and Without Access to a Post-trial Access Program
-
CLINICAL_TRIALS study record update · 2026-02-18Bright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-17Multiple Sclerosis Implementation Network
-
CLINICAL_TRIALS study record update · 2026-02-17Evaluation of Periodontal Status in Patients With Multiple Sclerosis: A Clinical, Microbiological, and Biochemical Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-17Investigation of the Relationship Between Chewing Function and Cognitive Functions, Disease Severity, and Nutritional Status in Individuals With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-17A Multicentre Non-interventional Study to Assess the Real-world Effectiveness of Ocrelizumab in Patients With Relapsing or Primary Progressive Multiple Sclerosis - The MuSicalE STUDY
-
CLINICAL_TRIALS study record update · 2026-02-17A Phase IIIb Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-17Objective Examination of Postural Instability Caused by Neurological Diseases
-
CLINICAL_TRIALS study record update · 2026-02-13Brain Aging - a Comparative Study in Healthy and Patients With Multiple Sclerosis as Model of a Chronic Neuroinflammatory Disorder (BrainAgeMS)
-
CLINICAL_TRIALS study record update · 2026-02-11A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA（QT-019C） in Patients With Relapsed / Refractory Neurological Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-02-11Effect of Sensory Integration Therapy on Gait Variability and Quality Of Life in Patients With Multiple Sclerosis: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-02-11A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
-
CLINICAL_TRIALS study record update · 2026-02-11In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases
-
CLINICAL_TRIALS study record update · 2026-02-10A Phase 1, Multicenter, Single-arm, Dose-escalation Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, Evaluating Safety and Tolerability in Participants With Autoimmune Neurological Diseases: Relapsing Forms of Multiple Sclerosis (RMS), Progressive Forms of Multiple Sclerosis (PMS), or Refractory Myasthenia Gravis (MG).
-
CLINICAL_TRIALS study record update · 2026-02-10Music-Augmented Versus Non-Music Technology-Based Rhythmic Gait Training in Multiple Sclerosis: A Randomized Controlled Trial of Gait Performance and Clinical Outcomes
-
CLINICAL_TRIALS study record update · 2026-02-09CorEvitas Multiple Sclerosis (MS) Registry
-
CLINICAL_TRIALS study record update · 2026-02-06Influence of Therapeutic Failure on the Psychosocial Experience of Patients With Relapsing-remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-06Home-Based Neuromodulation Suits for Reducing Spasticity and Ataxia in Multiple Sclerosis: A Multi-center RCT
-
CLINICAL_TRIALS study record update · 2026-02-06Effects of the MIND Diet on Fatigue, Quality of Life, and Brain Fog in Patients With Multiple Sclerosis: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-02-05A Pilot Study of Ublituximab in People With MS Experiencing Wearing Off Phenomena While Receiving Treatment With Ocrelizumab
-
CLINICAL_TRIALS study record update · 2026-02-04Evaluating the Retinal and Choroidal Microvasculature and Structure Using Multimodal Retinal and Choroidal Imaging in Neurodegenerative Disease: iMIND Research Study
-
CLINICAL_TRIALS study record update · 2026-02-04Validity and Reliability of the 6-minute Walk Test Over a Distance of 6 Metres in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-04Oral Cladribine B-cell Study
-
CLINICAL_TRIALS study record update · 2026-02-03Gamma Sensory Stimulation (GSS) for Improving Fatigue in People With Multiple Sclerosis